Beam Therapeutics Inc (BEAM)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt BEAM? Forum Prognose

Finanzdaten der Beam Therapeutics Inc-Aktie (BEAM)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	1,077% 114.11	9.698	8.466	7.47	30.07
Operating Expenses	3.63% 131.55	136.51	128.62	126.76	130.10
Benefits Costs and Expenses	206.34% -130.19	122.43	110.76	116.74	120.42
Costs And Expenses	206.34% -130.19	122.43	110.76	116.74	120.42
Depreciation and Amortization	1.94% 5.668	5.56	5.538	5.528	-
Operating Income/Loss	86.24% -17.45	-126.81	-120.15	-119.29	-100.04
Nonoperating Income/Loss	1,759% 261.74	14.08	17.86	10.02	9.683
Income/Loss From Continuing Operations Before Tax	316.71% 244.30	-112.73	-102.29	-109.27	-90.35
Income Tax Expense/Benefit	-	-	-	-	-
Income/Loss From Continuing Operations After Tax	316.71% 244.30	-112.73	-102.29	-109.27	-90.35
Net Income/Loss	316.71% 244.30	-112.73	-102.29	-109.27	-90.35
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	98.70% 1.3383	102.57	102.00	87.98	0.1716
Diluted Average Shares	98.70% 1.3383	102.57	102.00	87.98	0.1716
Basic Earnings Per Share	328.18% 2.51	-1.10	-1.00	-1.24	-1.09
Diluted Earnings Per Share	328.18% 2.51	-1.10	-1.00	-1.24	-1.09
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

MRNA

$48.77

0.87%

ROIV

$27.88

1.59%

RPRX

$47.32

2.57%

BNTX

$91.28

0.11%

ONC

$302.49

2.67%

INSM

$163.81

0.85%